Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
Speaker 2: The Stock Movers Report, your roundup of companies making moves
Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
Speaker 3: Now let's take a look at some of the stocks
Speaker 3: on the moves day in Europe. I'm Jaspecock with Karen Hepka,
Speaker 3: and we're joined by Bloomberg's Breaking News editor at Louise Moon. Louise,
Speaker 3: I'm going to take a shot in the dark that
Speaker 3: you want to talk to us about. Ask Doeseneca today
Speaker 3: I do?
Speaker 1: Indeed the big story in London markets today, Well I
Speaker 1: mean not just London markets really, So Astenaica have held
Speaker 1: talks to buy Bristol Meyers squib, the US farmer giant.
Speaker 1: So if this happened, it would be a huge deal.
Speaker 1: It would be the largest farms news called deal of
Speaker 1: all time. It created one of the world's biggest drug makers,
Speaker 1: so a big deal if it came about. Must say,
Speaker 1: the talks are an early stage and it's unclear if
Speaker 1: they're still ongoing. So these talks have been going on
Speaker 1: in recent months. If this were, you know, to come
Speaker 1: up about. On the positive side of it, Bristol Meyers
Speaker 1: last week reported its highest ever quarterly sales, and that
Speaker 1: growth was primarily driven by a lot of their newer products,
Speaker 1: so that included some of their cancer drugs, So that
Speaker 1: could be quite complimentary to AstraZeneca. It's become a cancer
Speaker 1: drug powerhouse under their CEO over the last few years,
Speaker 1: and it's been increasingly pivoting towards the US, so it
Speaker 1: kind of compliments both of those two things. On the
Speaker 1: negative side, and List are saying that this came as
Speaker 1: quite a surprise, and they're also saying that it kind
Speaker 1: of lacks strategic appeal for AstraZeneca. So jeffries I thought
Speaker 1: summed up quite nicely. They had a quote saying, given
Speaker 1: the strength of Astra's growth and innovation profile, we're a
Speaker 1: bit perplexed by the news, So yeah, a bit of
Speaker 1: a surprise. There also potentially there could be antitrust concerns
Speaker 1: as well, so a lot of uncertainties firstly if this
Speaker 1: is even going to come to fruition, but then secondly
Speaker 1: if it does try and go ahead, what hurdles that
Speaker 1: then comes up against. So AstraZeneca shares are actually down
Speaker 1: over seven percent this morning. They fell at one point
Speaker 1: to their lowes since October last year. Bristol, on the
Speaker 1: other hand, ticking slightly higher in pre market trading in
Speaker 1: the US.
Speaker 4: Yeah, I mean it's you know, it's also pretty unusual
Speaker 4: a UK well exactly listed business is having a go
Speaker 4: at a big US name I botted. Kind of very unusual,
Speaker 4: isn't it. It's been much more common to see over
Speaker 4: the last two to three years, if not longer, you know,
Speaker 4: UK fifty one hundred list businesses being snapped up by
Speaker 4: the US. Let's talk about Ryanair European airlines. I mean,
Speaker 4: you know, they've been really squeezed, as so many businesses
Speaker 4: have by the warner on and energy prices.
Speaker 1: Yes, and getting in terms of stop movements, getting a
Speaker 1: bit of an alleviation. Today the airlines are actually up
Speaker 1: across the board. So you've got Ryan, as you mentioned,
Speaker 1: up three percent, and then we're seeing this across the
Speaker 1: board from where their ig left hands a all on
Speaker 1: the back of this wider geopolitical news. So obviously oil
Speaker 1: is going down, that slide in Brent crude futures on
Speaker 1: the back of these potential talks that Trump has been
Speaker 1: speaking about, so benefiting the aviation space. Obviously, if oil
Speaker 1: is lower, that means that there's the prospect of jet
Speaker 1: fuel costs potentially coming down, so airlines up on the
Speaker 1: back of that, and obviously oil related stock SHELLBP down.
Speaker 4: Yeah, Travel and leisure as a sector in the U
Speaker 4: stock six hundred up by about one point seven percent.
Speaker 3: And then finally, Louis, let's talk about clarks which in
Speaker 3: the slew of earnings merits a mention because it's it
Speaker 3: seems to be quite stratospheric. It does.
Speaker 1: Shares up sixteen percent, so all time high today. So
Speaker 1: Clarkson is obviously the shipping consultancy, so this is also
Speaker 1: on the back of the Middle East as well. They've
Speaker 1: generated a record profit in their first half. In particular,
Speaker 1: their breaking division did really well, So essentially they're saying
Speaker 1: that it's been strong trading conditions. Obviously, all of the
Speaker 1: turbulence in the straight off Hormuz meant that freight rates
Speaker 1: are surging that they've also seen more hedging activity clients
Speaker 1: are trying to manage their exposure there. So it had
Speaker 1: a really good first half and they've boosted the outlook
Speaker 1: for the year as well. So, Yeah, sharesetting and all.
Speaker 2: The stockmover's report from Bloomberg Radio check back with us
Speaker 2: throughout the day for the latest roundup of companies making
Speaker 2: news on Wall Street, and for the latest market moving headlines.
Speaker 2: Listen to Bloomberg Radio Live, catch us on YouTube, Bloomberg
Speaker 2: dot com, and on Applecarplay and Android Auto with the
Speaker 2: Bloomberg Business app.